X0407 4 2023-06-16 0 0001601830 RECURSION PHARMACEUTICALS, INC. RXRX 0001852075 Dar Zavain C/O RECURSION PHARMACEUTICALS 41 S. RIO GRANDE STREET SALT LAKE CITY UT 84101 1 0 0 0 0 Class A Common Stock 2023-06-16 4 A 0 12612 0.00 A 70181 D Stock Option (Right to Buy) 8.92 2023-06-16 4 A 0 25224 0.00 A 2024-06-16 2033-06-16 Class A Common Stock 25224 25224 D Stock Option (Right to Buy) 6.20 2023-06-14 2032-06-14 Class A Common Stock 36290 36290 D Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy. The restricted stock units will vest on the earlier of June 16, 2024 or the day prior to the Issuer's 2024 annual meeting of stockholders, subject to Reporting Person's continued service to the Issuer. The shares subject to this option will vest and become exercisable on the earlier of June 16, 2024 or the date of the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer. /s/Jonathan Golightly, attorney-in-fact 2023-06-21